Galip Gürel, DDS, MSc, is the founder and honorary president of the Turkish Academy of Aesthetic Dentistry, a past president of the European Academy of Esthetic Dentistry, and a visiting professor at the New York University, Marseille Dental University, and Istanbul Yeditepe University. He received the 2014 Smigel Prize, which is granted biennially by New York University College of Dentistry to honor the best esthetic dentists in the world. Dr Gürel is the author of The Science and Art of Porcelain Laminate Veneers (Quintessence Publishing, 2003), which has been translated into 12 different languages. He is the editor-in-chief of Quintessence Magazine in Turkey and serves on the editorial boards for several journals.

1983 — 1989: Studium der Zahnmedizin an der RWTH Aachen. 1988 — 1992: Promotion zum Dr. med. dent. an der Klinik für Zahnerhaltung, Universitätsklinikum der RWTH Aachen. 1990 — 1998: Habilitation am Universitätsklinikum der RWTH Aachen mit dem Thema "Die Integration des Lasers in die Behandlung endodontischer Erkrankungen". 1992 — 1995: Master Degree of "Nd-YAG-Laser in Dentistry" an der UCSF (University California San Fransisco), USA. Seit 2003: apl Professor an der RWTH Aachen University. Seit 2004: Wissenschaftlicher Leiter des Masterstudiengangs "Lasers in Dentistry" an der RWTH Aachen MSc. in Laser Dentistry. Seit 2005: Assoc. Editor in "Journal of Lasers in Medical Science", Springer, London UK. 2005 — 2015: Präsident der Deutschen Gesellschaft für Laserzahnheilkunde DGL. 2008 — 2010: President World Federation for Laser Dentistry. Seit 2010: CEO Chief Executive Officer World Federation for Laser Dentistry WFLD. Seit 2012: Ehrenpräsident der World Federation for Laser Dentistry WFLD.

Chad Gwaltney, Ph.D. is President and Principal Consultant at Gwaltney Consulting. Dr. Gwaltney develops innovative methods to measure patient-centered outcomes in clinical trials. His academic and industry research includes the design of electronic platforms for the collection of information in real-time in the patient’s natural environment. He has published numerous articles and book chapters addressing how the patient’s perspective can be examined to better understand medical product efficacy and safety. He has served on US National Institutes of Health review committees and has co-authored ISPOR best practice guidelines on the development and use of patient-reported outcomes. Prior to founding Gwaltney Consulting, Dr. Gwaltney was Chief Scientist and Regulatory Advisor, Endpoints, at ERT. Dr. Gwaltney has also served as Head, Patient Experience, Hematology/Oncology, at Celgene and as a research faculty member in the Brown University School of Public Health.